Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Int J Mol Sci. 2022 Mar 16;23(6):3222. doi: 10.3390/ijms23063222.
Understanding the genetic factors of diabetes is essential for addressing the global increase in type 2 diabetes. HNF1A mutations cause a monogenic form of diabetes called maturity-onset diabetes of the young (MODY), and HNF1A single-nucleotide polymorphisms are associated with the development of type 2 diabetes. Numerous studies have been conducted, mainly using genetically modified mice, to explore the molecular basis for the development of diabetes caused by HNF1A mutations, and to reveal the roles of HNF1A in multiple organs, including insulin secretion from pancreatic beta cells, lipid metabolism and protein synthesis in the liver, and urinary glucose reabsorption in the kidneys. Recent studies using human stem cells that mimic MODY have provided new insights into beta cell dysfunction. In this article, we discuss the involvement of HNF1A in beta cell dysfunction by reviewing previous studies using genetically modified mice and recent findings in human stem cell-derived beta cells.
了解糖尿病的遗传因素对于应对全球 2 型糖尿病的增加至关重要。HNF1A 突变导致一种单基因形式的糖尿病,称为年轻起病的成年型糖尿病(MODY),HNF1A 单核苷酸多态性与 2 型糖尿病的发生有关。已经进行了许多研究,主要使用基因修饰小鼠,以探讨由 HNF1A 突变引起的糖尿病的分子基础,并揭示 HNF1A 在多个器官中的作用,包括胰腺β细胞的胰岛素分泌、肝脏中的脂质代谢和蛋白质合成以及肾脏中的尿葡萄糖重吸收。最近使用模拟 MODY 的人类干细胞的研究为β细胞功能障碍提供了新的见解。在本文中,我们通过回顾使用基因修饰小鼠的先前研究和人类干细胞衍生的β细胞中的最新发现,讨论了 HNF1A 参与β细胞功能障碍的情况。